Rennes University Hospital
Hospital in Brittany, France
48°07′15″N 1°41′47″W / 48.12083°N 1.69637°W / 48.12083; -1.69637The Rennes University Hospital (French: Centre hospitalier universitaire de Rennes or CHU Rennes) is a university hospital in Rennes in France. It employs 7,700 people[1] and processes nearly 1,500 hospitalisations per day. It was the second largest employer in the Rennes region.[2] It is one of 42 French hospital equipped with the da Vinci Surgical System.
In 2014, the Rennes University Hospital was ranked in the top 10 hospitals in France.[3]
Research
Research at CHU Rennes has included a study of the efficacy of nalmefene.[4][5]
In 2016, a facility run by the private contract research organization Biotrial, running clinical trials required patients to be admitted to CHU Rennes.[6] The facility ran a phase one study into a new drug being developed by Bial that targets the human endocannabinoid system.[7] The study failed catastrophically, leaving six subjects hospitalized and one brain dead.[8][9]
See also
References
- ^ Chiffres clefs 2007, www.chu-rennes.fr
- ^ Le pays de Rennes, INSEE, p. 113.
- ^ Le Point, magazine. "Hôpitaux - L'actualité Santé – Le Point".
- ^ "Study questions drug for alcohol cravings". news.
- ^ "PLOS Medicine".
- ^ "Rennes. Biotrial, un acteur important des essais thérapeutiques". Ouest-France.fr.
- ^ Lizzie Dearden (15 January 2016). "France clinical trial: Prosecutors investigating 'accident' as Biotrial defends drug testing safety record". The Independent.
- ^ "DIRECT- Accident thérapeutique à Rennes : les patients sont de l'Ouest". Ouest-France.fr.
- ^ "6 Hospitalized, One of Them Brain-Dead, After Drug Trial in France". The New York Times. 16 January 2016.
External links
- Official website
- PLOS journal affiliations
Authority control databases  | |
|---|---|
| International |
|
| National |
|
